Coeptis raises $1.1M convertible note and completes $10M Series A preferred stock sale

Z Squared Inc.

$1.1M convertible note to Yorkville with 8% interest, maturity Dec 31, 2025; conversion price with floor at $1.00.
Series A preferred stock sale raises ~$10M from accredited investors at $1,000 per share.
Preferred investors receive 13.91% non-voting equity in subsidiaries SNAP Biosciences and GEAR Therapeutics.
Board member Christopher Calise participated in the Series A offering.
Note includes amortization events triggering monthly payments of $250k principal plus 5% premium.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.